2.7 Non-Mendelian Inheritance (Mitochondrial, Imprinting, Multifactorial)
Key Takeaways
Mitochondrial DNA disorders are maternally transmitted; fathers with mtDNA disease generally do not pass mtDNA to offspring, while heteroplasmy and tissue thresholds drive variable severity
Genomic imprinting is parent-of-origin silencing; the same 15q11.2-q13 region yields Prader-Willi or Angelman phenotypes depending on whether paternal or maternal contribution is missing
Multifactorial traits reflect combined genetic liability and environmental exposures; the threshold model explains why recurrence rises with more affected relatives and greater severity
Heritability estimates the proportion of population phenotypic variance attributable to genetic differences—it is not an individual’s percent chance of developing disease
Non-Mendelian counseling fails when mitochondrial, imprinting, or multifactorial patterns are forced into 50%/25% single-gene scripts
2.7 Non-Mendelian Inheritance (Mitochondrial, Imprinting, Multifactorial)
Quick Answer: When pedigrees refuse Mendelian math, reach for three board frameworks: maternal mitochondrial (mtDNA) inheritance, genomic imprinting (parent-of-origin effects), and multifactorial/threshold disease with heritability as a population concept—not a personal probability.
These mechanisms appear across Domain 1 conditions and Domain 2 risk talks. Keep imprinting conceptual here; deep PWS/AS phenotype teaching belongs with chromosomal/imprinting syndrome chapters.
Mitochondrial Inheritance
Human mtDNA is transmitted through the oocyte. Clinical consequences:
| Principle | Counseling implication |
|---|---|
| Maternal transmission | A mother with a pathogenic mtDNA variant can transmit it to all children; a father with mtDNA disease typically does not transmit mtDNA disease to offspring |
| Heteroplasmy | Cells/tissues may carry a mixture of mutant and wild-type mtDNA |
| Threshold effect | Clinical disease often appears only when mutant load exceeds a tissue-specific threshold |
| Variable load | Heteroplasmy can differ among siblings and among tissues in one person → unpredictable severity |
| Bottleneck | A maternal bottleneck during oogenesis can shift heteroplasmy dramatically between generations |
Exam vignette cues: maternal lineage affected (mother, siblings, maternal aunts/uncles/cousins); no paternal transmission of the mtDNA trait; overlapping “mitochondrial” phenotypes (stroke-like episodes, myopathy, lactic acidosis, hearing loss, diabetes—pattern recognition, not a single pathognomonic list).
Nuclear vs mtDNA: Many mitochondrial diseases are caused by nuclear genes (Mendelian AR/AD/XL). Do not label every OXPHOS disorder “maternal inheritance.” Ask whether the variant is in mtDNA or nuclear DNA before quoting maternal-only transmission.
Practical counseling limits: Even with known maternal heteroplasmy, predicting a fetus’s load and phenotype is imprecise. Discuss reproductive options (including, where available and appropriate, mitochondrial replacement contexts as emerging/specialized topics) without overstating predictive precision of a single heteroplasmy percentage.
Genomic Imprinting (Parent-of-Origin Effects)
Imprinting means certain genes are expressed from only the maternal or only the paternal allele because of epigenetic marks established in gametogenesis.
| Concept | Board meaning |
|---|---|
| Parent-of-origin dependence | Deletion/UPD/epimutations matter based on which parent contributed the error |
| Same locus, different disease | Opposite phenotypes from loss of paternal vs maternal contribution |
| Not Mendelian segregation alone | Recurrence depends on mechanism (deletion vs UPD vs imprinting center vs single-gene), not a blanket 50% |
Clinical Link: Prader-Willi and Angelman (Mechanism Level)
Chromosome region 15q11.2-q13 is the classic teaching pair:
| Condition | Core genomic idea (keep brief) |
|---|---|
| Prader-Willi syndrome (PWS) | Lack of paternal contribution at the imprinted interval (paternal deletion, maternal uniparental disomy 15, or imprinting defect) |
| Angelman syndrome (AS) | Lack of functional maternal UBE3A contribution (maternal deletion, paternal UPD 15, imprinting defect, or maternal UBE3A pathogenic variant) |
Counseling point without duplicating syndrome depth: Mechanism determines recurrence. A de novo paternal deletion causing PWS has different recurrence implications than a familial imprinting-center variant or a maternal UBE3A variant causing AS. Always map parent of origin + molecular class before quoting numbers.
Other imprinting disorders (Beckwith-Wiedemann, Russell-Silver, and related growth syndromes) follow the same logic: phenotype tracks which parental allele is missing, duplicated, or epigenetically mis-set.
Multifactorial Inheritance and the Threshold Model
Multifactorial traits arise from combined polygenic liability plus environment (teratogens, nutrition, stochastic developmental noise, etc.). Congenital anomalies such as neural tube defects, cleft lip/palate, and many isolated heart defects are taught this way when not explained by a major Mendelian or chromosomal cause.
Threshold Model
Imagine a continuous liability distribution. Disease appears when liability crosses a threshold.
| Observation | Threshold-model explanation |
|---|---|
| Recurrence higher than population baseline after one affected child | Family shares elevated liability |
| Recurrence rises with ≥2 affected relatives | Greater shared genetic/environmental liability |
| More severe or bilateral defects → higher recurrence | More extreme liability in the family |
| Sex-differential thresholds | The less frequently affected sex may need higher liability to manifest → higher recurrence in relatives when the rare-sex proband is affected |
Empiric risks (published tables for specific anomalies) are used because single-locus Mendelian fractions do not apply. Quote condition-specific empiric figures; do not invent “25% multifactorial risk.”
Heritability at Board Level
Heritability (h²) estimates the fraction of phenotypic variance in a population attributable to genetic variance under a given environment. Critical clarifications:
| Heritability is | Heritability is not |
|---|---|
| A population statistic for a trait in a context | An individual’s percent chance of disease |
| Sensitive to environmental variation in the studied population | Proof that environment is unimportant when h² is high |
| Useful for understanding twin/family correlation patterns | A substitute for Mendelian counseling when a major gene is identified |
High heritability for height or schizophrenia-spectrum liability does not mean a counselor can tell one client “your risk is h².” For counseling, pair family history with empiric or Mendelian/genomic data appropriate to the case.
Side-by-Side: When to Leave Mendelian Scripts
| Clue in the case | Prefer this framework |
|---|---|
| Maternal-line mitochondrial features; no father-to-child mtDNA transmission | mtDNA inheritance + heteroplasmy/threshold |
| Opposite syndromes from 15q depending on parent of origin; UPD mentioned | Imprinting |
| Isolated common birth defect; mildly elevated sibling recurrence; no syndrome pattern | Multifactorial / empiric risks |
| Twin studies or “highly heritable” language without a gene | Heritability as population variance—not personal odds |
Session Structure
- Decide whether the pedigree fits Mendelian, mitochondrial, imprinting, or multifactorial first.
- For mtDNA, teach maternal transmission + heteroplasmy unpredictability without nuclear-gene confusion.
- For imprinting, name parent of origin and send mechanism-specific recurrence to the molecular result.
- For multifactorial anomalies, use threshold/empiric language and avoid forcing 50%/25%.
- Define heritability carefully if a stem uses the word—boards test misconceptions as often as definitions.
Non-Mendelian fluency prevents the most common Domain 2B error: applying autosomal recessive math to every “unaffected parents, affected child” vignette without checking mitochondria, imprinting, de novo dominant disease, or multifactorial liability.
A woman has a pathogenic mtDNA variant with variable heteroplasmy. Which statement is the most accurate reproductive counseling point?
None of her children can inherit the variant because mtDNA follows autosomal recessive rules
All of her sons will be affected and none of her daughters, because mtDNA is X-linked
She may transmit the variant to children of either sex, with severity influenced by heteroplasmy and tissue thresholds, whereas an affected father’s mtDNA is generally not transmitted to offspring
Her partner’s mtDNA genotype determines fetal risk because mitochondria are biparental in humans
A child has Angelman syndrome due to a maternal 15q11.2-q13 deletion. Which conceptual statement best explains why this is an imprinting-related diagnosis rather than simple autosomal recessive inheritance?
The phenotype depends on missing maternal contribution at an imprinted region (including maternal UBE3A function), so parent of origin—not merely biallelic autosomal variants—drives the mechanism
Angelman syndrome occurs only when both parents are silent carriers of an autosomal recessive allele on chromosome 15
Angelman syndrome is exclusively paternal mtDNA inheritance
Any deletion on chromosome 15 produces Angelman syndrome regardless of parental origin
In multifactorial counseling for an isolated congenital anomaly, which statement correctly applies the threshold model?
Recurrence risk is fixed at 25% after one affected child, as in autosomal recessive disease
Recurrence risk often increases above population baseline after an affected child and may rise further with additional affected relatives or greater severity, reflecting shared liability above a threshold
Heritability of 80% means each child has an 80% chance of the anomaly
Multifactorial anomalies never show familial clustering
Sections you finish are checked off in the contents.